The role of oxidative stress in renovascular hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 38, Issue 2, 2011, Pages 144-152

  Campos, Ruy R ^a   Oliveira Sales, Elizabeth B ^a   Nishi, Érika E ^a   Boim, Mirian A ^a   Dolnikoff, Miriam S ^a   Bergamaschi, Cássia T ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin II; AT1 receptors; Autonomic nervous system; Paraventricular nucleus of hypothalamus; Rostral ventrolateral medulla; Two kidney one clip rats

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ASCORBIC ACID; TEMPOL;

BLOOD PRESSURE; HEART RATE; HYPERTENSION; HYPOTHALAMUS; NONHUMAN; OXIDATIVE STRESS; PARAVENTRICULAR THALAMIC NUCLEUS; PRESSORECEPTOR REFLEX; RAT; RECEPTOR DOWN REGULATION; RENOVASCULAR HYPERTENSION; REVIEW; SYMPATHETIC NERVE; SYMPATHETIC TONE;

ANGIOTENSIN II; ANIMALS; BAROREFLEX; HUMANS; HYPERTENSION, RENOVASCULAR; KIDNEY; NADPH OXIDASE; OXIDATIVE STRESS; RATS; SYMPATHETIC NERVOUS SYSTEM;

EID: 79251485685     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2010.05437.x     Document Type: Review

References (57)

1. Lefebvre R, Genest J. Study of renal ischaemic tubular atrophy in 79 patients with arterial hypertension. Can. Med. Assoc. J. 1960; 82: 1249-53.
2. Sadjadi J, Puttaparthi K, Welborn MB et al. Upregulation of autocrine-paracrine renin-angiotensin systems in chronic renovascular hypertension. J. Vasc. Surg. 2002; 36: 386-92.
3. Goldblatt H, Lynch J, Hanzal R, Summerville W. Studies on experimental hypertension: I-the production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med. 1934; 59: 347-79.
4. Navar LG, Ichihara A, Chin SY, Imig JD. Nitric oxide-angiotensin II interactions in angiotensin II-dependent hypertension. Acta Physiol. Scand. 2000; 168: 139-47.
5. Wilcox CS, Cardozo J, Welch WJ. AT1 and TxA2/PGH2 receptors maintain hypertension throughout 2K, 1C Goldblatt hypertension in the rat. Am. J. Physiol. 1996; 271: R891-6.
6. Campos RR. Oxidative stress in the brain and arterial hypertension. Hypertens. Res. 2009; 32: 1047-8.
7. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 1994; 74: 1141-8.
8. Zimmermann MC, Lazartigues E, Lang JA et al. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ. Res. 2002; 91: 1038-45.
9. Gao L, Wang W, Li YL et al. Superoxide mediates sympathoexcitation in heart failure: Roles of angiotensin II and NAD(P)H oxidase. Circ. Res. 2004; 95: 937-44.
10. Babior BM. NADPH oxidase. Curr. Opin. Immunol. 2004; 16: 42-7.
11. Chabrashvili T, Tojo A, Onozato ML et al. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 2002; 39: 269-74.
12. Touyz RM, Yao G, Schiffrin EL. c-Src induces phosphorylation and translocation of p47phox: Role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2003; 23: 981-7.
13. Bokoch GM, Zhao T. Regulation of the phagocyte NADPH oxidase by Rac GTPase. Antioxid. Redox Signal. 2006; 8: 1533-48.
14. Heitzer T, Wenzer U, Hink U et al. Increased NAD(P)H oxidase mediated superoxide prodction in renovascular hypertension evidence for an involvement of protein kinase C. Kidney Int. 1999; 55: 52-260.
15. Oliveira-Sales EB, Dugaich AP, Abreu NP et al. Oxidative stress supports blood pressure and sympathetic activity in renovascular hypertension. Am. J. Hypertens. 2008; 21: 98-104.
16. Oliveira-Sales EB, Nishi EE, Carillo BA et al. Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. Am. J. Hypertens. 2009; 22: 484-92.
17. Prewitt RL, Dobrian AD, Schriver SD. Role of Angiotensin II and free radicals in blood pressure regulation in a rat model of renal hypertension. Hypertension 2001; 38: 361-6.
18. Laplante MA, Wu R, El Midaoui A, De Champlain J. NAD (P)H oxidase activation by angiotensin II is dependent on p 42/44 ERK-MAPK pathway activation in rats vascular smooth muscle cells. J. Hypertens. 2003; 21: 927-36.
19. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ. Res. 2004; 95: 210-6.
20. Wu L, De Champlain J. Effects of superoxide on signaling pathways in smooth muscle cells from rats. Hypertension 1999; 34: 1247-53.
21. De Champlain J, Wu RO, Girouard H et al. Oxidative stress in hypertension. Clin. Exp. Hypertens. 2004; 8: 593-601.
22. Nishikawa Y, Tatsumi K, Matsura T, Yamamoto A, Nadamoto T, Urabe K. Effects of vitamin C on high blood pressure induced by salt in spontaneously hypertensive rats. J. Nutr. Sci. Vitaminol. 2003; 49: 301-9.
23. Chen X, Touyz RM, Park JB, Schiffrin EL. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 2001; 38: 606-11.
24. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 2004; 109: 2357-62.
25. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N. Engl. J. Med. 2002; 346: 1954-62.
26. Duffy SJ, Gokce N, Holbrook M et al. Treatment of hypertension with ascorbic acid. Lancet 1999; 354: 2048-9.
27. Grossman E. Does increased oxidative stress cause hypertension? Diabetes Care 2008; 31: S185-9.
28. Lerman LO, Chade AR, Sica V, Napoli C. Animal models of hypertension: An overview. J. Lab. Clin. Med. 2005; 146: 160-73.
29. Welch WJ, Mendonca M, Aslam S, Wilcox CS. Roles of oxidative stress and AT1 receptors in renal hemodynamics and oxygenation in the postclipped 2K, 1C kidney. Hypertension 2003; 41: 692-6.
30. Palm F, Onozato F, Welch WJ, Wilcox CS. Blood pressure, blood flow, and oxygenation in the clipped kidney of chronic 2-Kidney, 1-clip rats: Effects of tempol and Angiotensin blockade. Hypertension 2010; 55: 298-304.
31. Lerman LO, Schwartz RS, Grande JP, Sheedy PJ, Romero JC. Noninvasive evaluation of a novel swine model of renal artery stenosis. J. Am. Soc. Nephrol. 1990; 10: 1455-65.
32. Lerman LO, Nath KA, Rodriguez-Porcel M et al. Increased oxidative stress in experimental renovascular hypertension. Hypertension 2001; 37: 541-6.
33. Campos RR, Bergamaschi CT. Neurotransmission alterations in central cardiovascular control in experimental hypertension. Curr. Hypertens. Rev. 2006; 2: 193-8.
34. Zimmerman MC, Dunlay RP, Lazartigues E et al. Requirement for Rac 1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ. Res. 2004; 95: 532-9.
35. Dampney RAL. Functional organization of central pathways regulating the cardiovascular system. Physiol. Rev. 1994; 74: 323-64.
36. Buttros JB, Bergamaschi CT, Ribeiro DA, Fracalossi AC, Campos RR. Cardioprotective actions of ascorbic acid during isoproterenol-induced acute myocardial infarction in rats. Pharmacology 2009; 84: 29-37.
37. Nishi EE, Oliveira-Sales EB, Bergamaschi CT, Oliveira TG, Boim MA, Campos RR. Chronic antioxidant treatment improves arterial renovascular hypertension and oxidative stress markers in the kidney in Wistar rats. Am. J. Hypertens. 2010; 23: 473-80.
38. Mathias CJ, Kooner JS, Peart S. Neurogenic components of hypertension in human renal artery stenosis. Clin. Exp. Hypertens. 1987; 1: 293-360.
39. Dampney RA, Fontes MA, Hirooka Y, Horiuchi J, Potts PD, Tagawa T. Role of angiotensin II receptors in the regulation of vasomotor neurons in the ventrolateral medulla. Clin. Exp. Pharmacol. Physiol. 2002; 29: 467-72.
40. Phillips MI, Sumners C. Angiotensin II in central nervous system physiology. Regul. Pept. 1998; 78: 1-11.
41. Ferguson AV, Bains JS. Actions of angiotensin in the subfornical organ and area postrema: Implications for long term control of autonomic output. Clin. Exp. Pharmacol. Physiol. 1997; 24: 96-101.
42. Ku YH, Jia YF, Chang YZ. Mechanisms underlying pressor response of subfornical organ to angiotensin II. Peptides 1999; 20: 171-6.
43. Potts PD, Hirooka Y, Dampney RA. Activation of brain neurons by circulating angiotensin II: Direct effects and baroreceptor-mediated secondary effects. Neuroscience 1999; 90: 581-94.
44. Allen AM, O'Callaghan EL, Bassi JK. Central regulation of cardiovascular function by angiotensin: A focus on the rostral ventrolateral medulla. Neuroendocrinol 2009; 89: 361-9.
45. Morishita R, Higaki J, Okunishi H et al. Role of tissue renin angiotensin system in two-kidney, one-clip hypertensive rats. Am. J. Physiol. 1993; 33: F510-4.
46. Nakada T, Kubota Y, Suzuki H, Sasagawa I, Watanabe M, Ishigooka M. Suppression of sympathetic nervous system attenuates the development of two-kidney, one-clip Goldblatt hypertension. J. Urol. 1996; 156: 1480-4.
47. Burke SL, Evans RG, Head GA. Effects of chronic sympatho-inhibition on reflex control of renal blood flow and plasma renin activity in renovascular hypertension. Br. J. Pharmacol. 2010; 159: 438-48.
48. Ye S, Nosrati S, Campese VM. Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF). J. Clin. Invest. 1997; 99: 540-8.
49. Li Z, Mao HZ, Abboud FM, Clapleau MW. Oxygen-derived free radicals contribute to baroreceptor dysfunction in atherosclerotic rabbits. Circ. Res. 1996; 79: 802-11.
50. Kishi T, Hirooka Y, Kimura Y et al. Overexpression of eNOS in RVLM improves impaired baroreflex control of heart rate in SHRP Rostral ventrolateral medulla. Stroke prone spontaneously hypertensive rats. Hypertension 2003; 41: 255-60.
51. Leclerc PC, Proulx CD, Arguin G et al. Ascorbic acid decreases the binding affinity of the AT1 receptor for angiotensin II. Am. J. Hypertens. 2008; 21: 67-71.
52. Dibona GF, Kopp UC. Neural control of renal function. Physiol. Rev. 1997; 77: 75-197.
53. Katholi RE, Whitlow PL, Winternitz SR, Oparil S. Importance of the renal nerves in the established two-kidney, one clip hypertension. Hypertension 1982; 4(Suppl. II): 166-74.
54. Harrison JL, Hildreth CM, Gallaham SM, Goodchild AK, Phillips JK. Cardiovascular autonomic dysfunction in a novel rodent model of polycystic kidney disease. Auton Neurosci. 2010; 152: 60-6.
55. Carlström M. Causal link between neonatal hydronephrosis and later development of hypertension. Clin. Exp. Pharmacol. Physiol. 2010; 37: e14-23.
56. Schlaich MP, Sobotka PA, Krum H, Labert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N. Engl. J. Med. 2009; 361: 932-4.
57. Oliveira-Sales EB, Colombari DS, Davisson RL et al. Kidney-induced hypertension depends on superoxide signaling in the rostral ventrolateral medulla. Hypertension 2010; 56: 290-6.